| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43cf0d6f748d51ee4f9d15b009c7d188
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7305fcecacebf094c6b6ae08fb411c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac316c4307d2a84add2bae0328f607bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2baea8173c44ae1b7cffd8af9d497a1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f4ead6158fa635796a5fa4d48ffc357a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_553dacc887d8d863657df8afa9793b9e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16043 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-867 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-867 |
| filingDate |
2005-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0989745599141ee243c6d655526cf383
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9514ee02806f7d75b6a4b596680e62ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea18d1cca13a52f7f0c2211fd28527bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ecd1e83633c33642acab09fcf3d3c4d |
| publicationDate |
2005-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005108588-A1 |
| titleOfInvention |
Novel hiv-based recombinant viral clones and use thereof in analytical methods |
| abstract |
The invention relates to HIV-based recombinant viral clones having the general structure shown in the accompanying figure, which are the result of the following genetic manipulations: deletion of HIV fragments (e.g. the Nef gene) without loss of infective capacity; insertion of a gene that is not expressed in human cells; insertion of the LacZ gene; and introduction of restriction sites, in order to extract DNA fragments from the matrix provirus and substitute same with genes from the patients to be assessed. In addition, the invention relates to the application of said clones in analytical methods that are associated with AIDS. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8673551-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007065926-A1 |
| priorityDate |
2004-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |